
Quarterly Result5 Nov 2026, 01:05 pm
Fermenta Biotech declares Q2 FY27 Unaudited Financial Results
AI Summary
Fermenta Biotech Limited announced the approval of its Unaudited Financial Results (Standalone and Consolidated) for the quarter and half-year ended September 30, 2026. The Board of Directors met on November 05, 2026, to approve these results. The company also received Limited Review Reports from its statutory auditors, M/s. SRBC & Co. LLP, with an unmodified opinion. The board meeting commenced at 12:00 p.m. IST and concluded at 12:39 p.m. IST.
Key Highlights
- Board approved unaudited financial results for Q2 FY27.
- Results were declared on a standalone and consolidated basis.
- Limited Review Reports received from auditors.
- Auditors provided an unmodified opinion on the results.
- Board meeting concluded within an hour.
Price Impact
More from FERMENTA